Showing results (111-120 of 199) with videos related to

Sort By:
Pageof 20
ACR Open Rheumatology|June 21, 2026
Italian Olfactory Identification Test in Systemic Lupus Erythematosus: Association of Olfactory Impairment With Chronic Damage and Anti-β<sub>2</sub>-Glycoprotein I AntibodiesMarta Di Berardino, Pasquale Nigro, Lorenza Bruno, et al.
Rheumatology (Oxford, England)|August 12, 2025
Phenotypic clusters of long-term damage in Sjögren's disease: a 15-year multicentre studyGiacomo Cafaro, Beatrice Dei, Roberto Dal Pozzolo, et al.
Clinical and Experimental Rheumatology|July 30, 2020
COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19)Carlo Alberto Scirè, Greta Carrara, Anna Zanetti, et al.
Clinical and Experimental Rheumatology|August 30, 2018
Discrepancy between subjective symptoms, objective measures and disease activity indexes: the lesson of primary Sjögren's syndromeAlessia Alunno, Elena Bartoloni, Valentina Valentini, et al.
Seminars in Arthritis and Rheumatism|June 18, 2014
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjögren׳s syndrome? Association between clinical, histopathological, and molecular features: a retrospective studyFrancesco Carubbi, Alessia Alunno, Paola Cipriani, et al.
Clinical and Experimental Rheumatology|July 13, 2018
The prevalence and relevance of traditional cardiovascular risk factors in primary Sjögren's syndromeElena Bartoloni, Alessia Alunno, Valentina Valentini, et al.
Clinical and Experimental Rheumatology|October 23, 2020
Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsyGiacomo Cafaro, Carlo Perricone, Chiara Baldini, et al.
The Journal of Rheumatology|May 17, 2017
Cryoglobulinemia in Sjögren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid TissueLuca Quartuccio, Chiara Baldini, Roberta Priori, et al.
Annals of Internal Medicine|May 2, 2007
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trialCarlo Salvarani, PierLuigi Macchioni, Carlo Manzini, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: results of an Italian observational studyRoberto Caporali, Luca Idolazzi, Stefano Bombardieri, et al.
Pageof 20